This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

SunLink Health Systems, Inc. Unusual Trading Activity

SunLink Health Systems, Inc. (NYSE/Amex: SSY) announced that its policy is to not comment on unusual market activity or rumors.

In view of the unusual market activity in the stock of SunLink Health Systems, Inc. (NYSE Amex: SSY), the NYSE has contacted the company in accordance with its usual practice; the company stated that its policy is not to comment on unusual market activity or rumors.

The company noted that on April 8, 2011 SunLink Health Systems, Inc. and Foundation Healthcare Affiliates announced a preliminary agreement and letter of intent for a non-cash merger. The company also noted the contemplated transaction is subject to a number of conditions, including due diligence by each of the parties, negotiation and execution of a definitive agreement and consent of lenders; and that there can be no assurance the proposed transactions contemplated will in fact be consummated or, if consummated, that the terms and conditions will not be changed.

About SunLink Health Systems, Inc

SunLink Health Systems, Inc. currently operates seven community hospitals, three nursing homes and one home care business in the Southeast and Midwest and its specialty pharmacy business, SunLink ScriptsRx, in Louisiana. Each SunLink hospital is the only hospital in its community. SunLink’s operating strategy is to link patients’ needs with dedicated physicians and health professionals to deliver quality, efficient medical care and healthcare products and services in each area it serves. For additional information on SunLink Health Systems, Inc., please visit the company’s website at www.sunlinkhealth.com.

Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,521.20 +80.61 0.46%
S&P 500 2,079.03 +11.39 0.55%
NASDAQ 5,047.0760 +7.30 0.14%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs